Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

SRPT Deadline: SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit

Summary by TBNweekly
NEW YORK, Aug. 8, 2025 /PRNewswire/ -

19 Articles

PR NewswirePR Newswire
Reposted by
CNHI NewsCNHI News
Center

SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

/PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June...

·United States
Read Full Article
Bennington BannerBennington Banner
+16 Reposted by 16 other sources
Center

SRPT Deadline: SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 8, 2025 /PRNewswire/ -

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources are Center
63% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

TBNweekly broke the news in on Friday, August 8, 2025.
Sources are mostly out of (0)

Similar News Topics

New York City icon

New York City

News
For You
SearchBlindspotLocal